GEMP - Gemphire Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2026-02-05)
Last
 1.73		 Change
 ⇓ -0.13   (-6.99%)		 Volume
  188,897
Open
 1.85		 High
 1.85		 Low
 1.66
8EMA (Daily)
 2.26		 40EMA (Daily)
 4.36		 50EMA (Daily)
 4.36		 STO (Daily)
 2.397		 MACD Hist (Daily)
 0.080
8EMA (Weekly)
 4.121		 40EMA (Weekly)
 3.00		 50EMA (Weekly)
 2.81		 STO (Weekly)
 24.103		 MACD Hist (Weekly)
 -0.859
Company Profile
Gemphire Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing and commercializing therapies for patients with cardiometablic disorders including dyslipidemia and nash.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com